Investing.com - Stifel downgraded Alcon Inc. (NYSE:ALC) from Buy to Hold and lowered its price target to $80.00 from $85.00 on Friday. The new target aligns closely with Alcon’s current trading price ...

Eyecare giant Alcon has bought a majority stake in cell therapy start-up Aurion Biotech, replacing the company's chief executive, in the culmination of a months-long struggle for control. In a ...

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today terminated its definitive merger agreement with STAAR Surgical Company ...

Unity (U) appears to have successfully initiated a turnaround. The company is finally back to positive growth, as its AI-powered advertising engine is operating in full force. This is a name that had ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...